To renew the Companys authorization, with approval of its Board of Directors, to sell shares of its common stock (during the next 12 months) at a price or prices below the Companys then current net asset value per share in one or more offerings subject to certain conditions as set forth in the accompanying proxy statement (including that the number of shares sold on any given date does not exceed 25% of its outstanding common stock immediately prior to such sale).